As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 3/15/24  Coherus BioSciences, Inc.         10-K       12/31/23  142:19M                                    Toppan Merrill Bridge/FA 
  2/8/23  Novartis Institutes for BioM… Inc SC 13G                 3:72K  Third Harmonic Bio, Inc.          Toppan Merrill/FA        
          Novartis AG³
10/26/21  CFSB Bancorp, Inc./MA             CORRESP¶   12/10/21    1:12K                                    Donnelley … Solutions/FA 
 10/8/21  Novartis Pharma AG                SC 13G                 3:121K SomaLogic, Inc.                   Toppan Merrill/FA        
          Novartis AG³
          Novartis Institutes for Biomedical Research, Inc.³
  7/1/21  Caribou Biosciences, Inc.         S-1                   63:9.8M                                   Donnelley … Solutions/FA 
 6/17/21  Intellia Therapeutics, Inc.       8-K:1,8,9   6/14/21   11:242K                                   ActiveDisclosure/FA      
  5/7/21  Caribou Biosciences, Inc.         DRS¶         7/1/21   59:8.8M                                   Donnelley … Solutions/FA 
 4/23/21  TScan Therapeutics, Inc.          S-1                   27:9.7M                                   Donnelley … Solutions/FA 
 3/19/21  TScan Therapeutics, Inc.          DRS¶        4/23/21    4:7.2M                                   Donnelley … Solutions/FA 
 2/23/21  Novartis Bioventures Ltd.         SC 13G/A               1:76K  Adicet Bio, Inc.                  Toppan Merrill/FA        
          Novartis AG³
          Novartis Institutes for Biomedical Research, Inc.³
  2/8/21  Novartis Institutes for BioM… Inc SC 13G/A               2:71K  Surface Oncology, Inc.            Toppan Merrill/FA        
          Novartis AG³
  2/5/21  Novartis Institutes for BioM… Inc SC 13G                 3:78K  Old Ayala, Inc.                   Toppan Merrill/FA        
          Novartis AG³
  2/1/21  Novartis Bioventures Ltd.         SC 13G/A               2:85K  Adicet Bio, Inc.                  Toppan Merrill/FA        
          Novartis AG³
          Novartis Institutes for Biomedical Research, Inc.³
 1/22/21  Novartis Institutes for BioM… Inc SC 13D/A               1:162K Intellia Therapeutics, Inc.       Toppan Merrill/FA        
          Novartis AG³
 11/9/20  Homology Medicines, Inc.          10-Q        9/30/20   69:9.2M                                   ActiveDisclosure/FA      
 9/22/20  Novartis Bioventures Ltd.         SC 13G/A               4:158K Adicet Bio, Inc.                  Toppan Merrill/FA        
          Novartis AG³
          Novartis Institutes for Biomedical Research, Inc.³
 8/20/20  Novartis Institutes for BioM… Inc SC 13D/A               1:125K Intellia Therapeutics, Inc.       Toppan Merrill/FA        
          Novartis AG³
 8/10/20  Homology Medicines, Inc.          10-Q        6/30/20   66:8.6M                                   ActiveDisclosure/FA      
  3/3/20  Brown Scott A                     4          Officer²    2:7K   Teradata Corp./DE                 DONNELLEY FIN… File16/FA 
 6/24/19  Brown Scott A                     3          Officer²    2:7K   Teradata Corp./DE                 DONNELLEY FIN… File16/FA 

____________
¹	Filing/Form Types:  -K
	3	Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }.
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	10-Q	Quarterly Report — Form 10-Q.
	CORRESP	Comment-Response or Other Letter to the SEC.
	DRS	Draft Registration Statement by an Emerging Growth Company or Foreign Issuer — Form DRS.
	S-1	Registration Statement (General Form) — Form S-1.
	SC 13D	Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D.
	SC 13G	Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
	¶	This Filing contains a delayed-release Document.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.
³	Group Member:  A Registrant or non-Registrant party to this Filing made by a Group.